| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |